Drosophila melanogaster casein kinase II (DmCKII) is composed of catalytic (␣) and regulatory () subunits associated as an ␣ 2  2 heterotetramer. Using the twohybrid system, we have screened a D. melanogaster embryo cDNA library for proteins that interact with Dm-CKII␣. One of the cDNAs isolated in this screen encodes m7, a basic helix-loop-helix (bHLH)-type transcription factor encoded by the Enhancer of split complex (E(spl)C), which regulates neurogenesis. m7 interacts with DmCKII␣ but not with DmCKII, suggesting that this interaction is specific for the catalytic subunit of Dm-CKII. In addition to m7, we demonstrate that DmCKII␣ also interacts with two other E(spl)C-derived bHLH proteins, m5 and m8, but not with other members, such as m3 and mC. Consistent with the specificity observed for the interaction of DmCKII␣ with these bHLH proteins, sequence alignment suggests that only m5, m7, and m8 contain a consensus site for phosphorylation by CKII within a subdomain unique to these three proteins. Accordingly, these three proteins are phosphorylated by DmCKII␣, as well as by the ␣ 2  2 holoenzyme purified from Drosophila embryos. In line with the prediction of a single consensus site for CKII, replacement of Ser 159 of m8 with either Ala or Asp abolishes phosphorylation, identifying this residue as the site of phosphorylation. We also demonstrate that m8 forms a direct physical complex with purified DmCKII, corroborating the observed two-hybrid interaction between these proteins. Finally, substitution of Ser 159 of m8 with Ala attenuates interaction with DmCKII␣, whereas substitution with Asp abolishes the interaction. These studies constitute the first demonstration that DmCKII interacts with and phosphorylates m5, m7, and m8 and suggest a biochemical and/or structural basis for the functional equivalency of these bHLH proteins that is observed in the context of neurogenesis.
Casein kinase II (CKII)1 is a ubiquitous protein kinase that is highly conserved among eukaryotes (1, 2) and is capable of functioning as an oncogene in mammals (3). CKII is composed of catalytic (␣) and regulatory () subunits that combine to form an ␣ 2  2 holoenzyme. With the exceptions of Drosophila melanogaster (4), Caenorhabditis elegans (5), and Schizosaccharomyces pombe (6), CKII from most eukaryotic organisms contains two ␣ subunits, ␣ and ␣Ј, that are encoded by distinct genes. In contrast,  subunit heterogeneity has been documented via protein microchemical approaches in Saccharomyces cerevisiae (7) and via molecular/genetic approaches in Arabidopsis thaliana (8) and D. melanogaster (9).CKII preferentially phosphorylates Ser/Thr residues in an hyperacidic context (10), although phosphorylation of Tyr has been documented in at least one case, i.e. yeast Fpr3 (11). Analysis of the phosphorylation of synthetic peptides suggests that the consensus site for phosphorylation by CKII can best be described as (S/T)(D/E)X(D/E) (10). Consistent with this, a number of proteins critical for transcription, cell cycle regulation, and s...